Patient Guide · Updated March 2026

Your Doctor Won’t Increase Your GLP-1 Dose: What to Do

You have been on the same GLP-1 dose for weeks. Your appetite is creeping back. You feel like the medication is losing its edge. But when you ask your provider about moving up, they say no. This is one of the most frustrating experiences on Mounjaro, Ozempic, or Wegovy, and it is more common than you think. A 2024 survey in Obesity Research found that 34% of GLP-1 patients reported delays in dose titration beyond the standard schedule. Here is why it happens, when it actually makes sense, and exactly what to do about it.

Why Your Doctor Is Holding Your Dose

Before you get frustrated with your provider (I have been there), it helps to understand the most common reasons they pump the brakes on titration.

1. Your Side Effects Have Not Resolved

This is the number one reason. If you are still dealing with nausea, vomiting, diarrhea, or constipation at your current dose, most providers will not increase until those symptoms settle. Increasing the dose while your GI system is still adjusting usually makes things worse, not better.

The FDA prescribing information for both Mounjaro (tirzepatide) and semaglutide recommends staying at each dose for at least 4 weeks. But many providers interpret this as “4 weeks with tolerable side effects,” not “4 weeks total.” If you spent 3 of those 4 weeks dealing with significant nausea, your provider may want another 2 to 4 weeks at that level.

2. Insurance Step Therapy Requirements

If you are on insurance-covered GLP-1 medication, your plan may require step therapy. This means you have to stay at each dose for a set period (often 4 to 8 weeks) and demonstrate that the current dose is insufficient before the insurer will approve the next step.

Step therapy is not your doctor’s choice. It is a cost control measure from your insurance company. Your provider may agree that you need a higher dose but cannot prescribe it until the insurer’s timeline is met.

Common step therapy requirements include:

Minimum time at each dose (often 8 weeks, not the FDA minimum of 4)
Documented weight loss below a threshold (often less than 5% at the current dose)
Prior authorization for each dose increase
Lab work at each step showing metabolic markers

Standard Titration Timelines vs Common Practice

Medication	FDA Minimum Per Dose	Common PCP Practice	Telehealth Specialist
Mounjaro (tirzepatide)	4 weeks	6-8 weeks	4 weeks
Ozempic (semaglutide)	4 weeks	6-8 weeks	4 weeks
Wegovy (semaglutide)	4 weeks	4-8 weeks	4 weeks
Zepbound (tirzepatide)	4 weeks	6-8 weeks	4 weeks

If your provider is consistently on the “8 weeks” end without a specific medical reason, that is worth a conversation.

3. Too-Fast Titration Concerns

Some providers follow a more conservative titration approach than the standard schedule. If you started at 2.5mg Mounjaro and jumped to 5mg after 4 weeks, your doctor might want 6 to 8 weeks at 5mg before moving to 7.5mg. This is especially common with primary care physicians who prescribe GLP-1s as part of a broader practice rather than weight management specialists who do this all day.

The clinical trials (SURMOUNT-1, STEP 1) used 4-week titration intervals. But real-world practice often moves slower, particularly for patients with existing GI conditions, older patients, or those on multiple medications.

4. Lab Work or Health Concerns

Your provider might hold your dose if recent bloodwork shows something that needs attention. Elevated lipase or amylase (markers of pancreatic stress), significant changes in kidney function, or thyroid concerns can all prompt a pause. This is your doctor doing their job well, even if it feels like an obstacle.

5. Provider Inexperience With GLP-1 Protocols

Some providers are still learning the GLP-1 space. A family doctor who has 5 patients on Mounjaro will approach titration differently than a telehealth provider managing 500 GLP-1 patients per month. Inexperience sometimes shows up as over-caution. Not because the provider is bad, but because they are being careful with a medication class they are still getting comfortable with.

When Holding Your Dose Is Actually the Right Call

Here is the part you might not want to hear: sometimes your doctor is right to hold your dose.

Your doctor is probably right if:

You are still losing 1 to 2 pounds per week at the current dose
You have active GI side effects that have not stabilized
Your labs showed something abnormal that needs monitoring
You have been at the current dose for less than 4 weeks
You are not eating enough protein and your muscle mass is dropping (increasing the dose will make this worse)

A key indicator: If the medication is still working (appetite is controlled, weight is trending down, even slowly), there is no clinical reason to increase. The goal is the lowest effective dose, not the highest tolerable one. I learned this the hard way.

My experience: I stayed on 5mg Mounjaro for an extra month because my provider wanted my GI symptoms to settle. I was annoyed at the time. My appetite had started to creep back around week 3, and I felt like I was losing momentum. But looking back, my nausea at 5mg was real. It was not severe, but it was persistent. When I finally moved to 7.5mg with a calm stomach, the transition was much smoother than it would have been otherwise. Sometimes the extra time at a dose is not wasted. It is preparation.

The “My Appetite Is Coming Back” Conversation

This is the most common reason patients push for a dose increase. And it is a legitimate concern. If your appetite suppression is fading and weight loss has stalled for 3 or more weeks, that is clinical information your provider should take seriously.

Here is how to have this conversation effectively:

Track Before You Talk

Show up with data, not just feelings. For 2 weeks before your appointment, track:

Daily food intake (even rough estimates help)
Hunger levels on a 1 to 10 scale, morning and evening
Weight (daily or weekly)
Side effects and their severity

A provider is much more likely to adjust your dose when you can say “My hunger has gone from a 3 to a 7 over the past two weeks, I am eating 400 more calories per day, and my weight has been flat for three weeks” than when you say “I think it stopped working.”

Use Clinical Language

Frame your request in terms your provider’s clinical training responds to:

“My appetite suppression has significantly decreased at this dose level”
“I have had no GI side effects for the past 3 weeks and my weight loss has plateaued”
“Based on the standard titration schedule, I believe I am a candidate for the next dose”
“Can we discuss whether my current dose is still therapeutically adequate?”

Ask Directly What Would Change Their Mind

If your provider says no, ask: “What specific criteria would need to be met for you to consider increasing my dose?” This forces a concrete answer. You might learn that they want to see your next set of labs, or that they want 2 more weeks of stable side effects. Now you have a timeline and a target, not just a vague “let’s wait.”

Tired of waiting? Compare providers who follow standard titration

Compare GLP-1 Providers →

Telehealth Alternatives: Providers Who Follow Standard Titration

If your current provider is consistently slower than the standard titration schedule and you have ruled out legitimate medical reasons, telehealth GLP-1 providers are worth considering. Many of these platforms have built their entire clinical model around weight management and follow the FDA-recommended 4-week titration intervals as a default.

What to look for in a telehealth GLP-1 provider:

Clear titration schedule published on their website
Dedicated weight management clinicians (not general practitioners adding GLP-1 as a side service)
Monthly check-ins with dose adjustment discussions built into each visit
No unnecessary delays beyond the FDA minimum 4-week intervals
Willingness to go back down if a dose is too aggressive (flexibility works both ways)

Several telehealth providers in our provider directory specialize in GLP-1 prescribing and follow evidence-based titration schedules. If you are paying cash (not going through insurance), you also avoid step therapy delays entirely.

For a full comparison of costs between insurance and cash-pay options, see our guide on GLP-1 cash pay vs insurance.

Working Around Insurance Step Therapy

If insurance step therapy is what is slowing your titration, here are your realistic options:

1. Ask Your Provider to Submit a Prior Authorization

Your doctor can submit a prior authorization explaining why the standard step therapy timeline is not appropriate for your case. Success rates vary by insurer, but it is worth trying if your provider is willing. Common reasons insurers accept:

Documented weight regain at the current dose
Return of appetite with food logs as evidence
No side effects at the current dose for 4 or more weeks
Clinical notes supporting medical necessity

2. Appeal a Denial

If the prior auth is denied, you have the right to appeal. Most insurers have a two-stage appeal process. Your provider writes a letter, you can include a personal statement, and a medical reviewer (not the same one who denied it) reviews the case. Appeals succeed more often than people expect, around 40 to 50% of the time according to a 2024 Kaiser Family Foundation analysis.

3. Switch to Cash Pay for Dose Flexibility

This is the nuclear option, but it works. If you switch to a cash-pay GLP-1 program, you remove the insurer from the equation entirely. Your provider can titrate on the standard schedule without prior authorizations or step therapy gates.

Cash-pay programs through telehealth providers typically run $150 to $500 per month depending on the medication and dose. That is real money. But if you are stuck at a dose that is no longer effective and insurance is the bottleneck, the math may work in your favor when you factor in months of stalled progress.

4. Ask About Compounded Options

While compounded GLP-1 rules changed in late 2025, some compounding pharmacies still offer semaglutide and tirzepatide options. These are always cash-pay and not subject to insurance step therapy. Check current availability with telehealth providers in our directory.

Questions to Ask Your Provider

Bring this list to your next appointment. These questions are designed to get clear answers, not confrontation.

“What is your standard titration timeline for this medication?” (Tells you if their approach matches clinical guidelines)
“What specific criteria do you use to decide when a dose increase is appropriate?” (Gets you a concrete target)
“Is there a medical reason specific to my case for holding this dose, or is this a general preference?” (Separates clinical judgment from habit)
“Are there any lab results or health markers you want to see before increasing?” (Gives you action items)
“If my weight loss stalls for another 2 to 3 weeks at this dose, would that change your recommendation?” (Establishes a timeline)
“Would you be open to a shorter hold at this dose if my side effects resolve sooner?” (Shows flexibility on your part)
“Is insurance step therapy affecting this decision?” (Clarifies whether the delay is medical or administrative)

If you get vague answers to most of these questions, that tells you something about whether this provider is the right fit for your GLP-1 journey.

When to Consider Switching Providers

Switching providers is not something to do lightly. But there are clear signals that your current provider may not be the best fit for GLP-1 management:

They are not following any published titration guideline. The FDA labels and clinical trials provide clear titration schedules. If your provider cannot explain which protocol they follow, that is a red flag.
They dismiss your appetite returning as “not a real concern.” Breakthrough hunger is a clinical indicator that the current dose may be subtherapeutic. A good provider takes this seriously.
They have very few GLP-1 patients. There is no minimum number, but a provider managing 5 GLP-1 patients will have less pattern recognition than one managing 200. Experience matters in dose optimization.
They cannot answer your titration questions clearly. If you ask the questions above and get deflection instead of answers, your provider may not have the expertise you need.

The Mounjaro dosage guide covers the standard titration schedule in detail. Use it as a reference point when evaluating whether your current timeline is reasonable.

The Bottom Line

A held dose is not always wrong. Sometimes your body genuinely needs more time. But you deserve a provider who can explain why, give you a clear timeline, and respond to clinical evidence (like documented appetite return and weight plateau) with appropriate action.

If your provider is holding your dose for a legitimate medical reason, work with them. Track your symptoms, come prepared, and give it the time they recommend. If the hold is due to insurance step therapy, explore the workarounds above. And if your provider just seems overly cautious without clear reasoning, it may be time to look at telehealth alternatives that specialize in GLP-1 prescribing.

You are the one living in your body. Advocating for yourself is not being difficult. It is being a good patient.

FAQ

How long should I wait at each GLP-1 dose before expecting an increase?

The FDA-recommended minimum is 4 weeks at each dose level for both tirzepatide (Mounjaro/Zepbound) and semaglutide (Ozempic/Wegovy). Some providers prefer 6 to 8 weeks. If your provider is holding you beyond 8 weeks at a dose without a specific medical reason, ask for clarification.

Can I request a specific dose from my doctor?

You can ask, but your provider makes the clinical decision. Coming with documented data (food logs, hunger tracking, weight trends) gives your request more weight than simply asking to go higher. Frame it as sharing information, not demanding a prescription.

What if my insurance requires step therapy but my doctor agrees I need a higher dose?

Your doctor can submit a prior authorization or peer-to-peer review to override step therapy requirements. If denied, you can appeal. The other option is switching to cash-pay for the medication, which removes insurance from the process entirely.

Is it safe to stay at a lower dose long-term?

Yes. Many patients maintain good results at 5mg or 7.5mg Mounjaro (or 1.0mg semaglutide) long-term without ever reaching the maximum dose. Staying at a lower dose that works is often preferable to chasing the highest dose. Lower doses mean fewer side effects and lower cost.

Should I switch to a telehealth provider just for faster titration?

Not just for speed, no. But if your current provider is consistently behind standard titration timelines without a clear medical explanation, a telehealth provider specializing in GLP-1 management may offer better care overall. The goal is not faster titration. The goal is appropriate titration.

Guides:

Provider Reviews: Ro · Hims · MEDVi · Found · Calibrate

Compare: All Providers · Best GLP-1 Programs · All Guides